Lipid-Related Residual Risk of Microvascular Complications in Patients with Type 2 Diabetes

Lipid-Related Residual Risk of Microvascular Complications in Patients with Type 2 Diabetes - Lipid-Related Residual Risk of Microvascular Complications in Patients with Type 2 Diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003280

Enrollment

174

Registered

2010-03-03

Start date

2010-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes dyslipidemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: At least one documented microvascular complication: Diabetic retinopathy Diabetic maculopathy Diabetic nephropathy LDL-C<130 mg/dl with or without statin therapy

Exclusion criteria

Exclusion criteria: Type 1 diabetes, congestive heart failure, active cancer treatment, organ transplant recipients, end stage renal disease, autoimmune diseases, HIV, substance abuse, severe liver disease, Non-diabetic kidney disease, except if accompanied by a known microvascular complication of diabetes

Design outcomes

Primary

Measure	Time frame
1) The prevalence of low plasma levels of HDL cholesterol(HDL-C) and/or elevated plasma levels of triglycerides. 2) Whether low HDL-C and/or elevated TG levels are associated with a significant risk of microvascular complication of diabetes after adjustment on other risk factors.	—

Countries

Japan

Outcome results